ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer.

Saisai Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.